Based on these data, the IGF-1 drug itself does not cause oncology, but only has a contraindication to use if you already have cancer or its predisposition (high cancer markers)
It is HoMEso's first serum designed for both skin and scalp, supported by HoMEso micro-infusion for enhanced topical delivery
16-19 Published online:May 15, 2013 Article type:Research Article Received:Mar 16, 2013 Accepted:Apr 24, 2013 How to Cite:Shekarforoush S, Aghababa H, Azizi M, Changizi-Ashtiyani S, Zarei A, et al
Third-Party Tested Batch & Lot Tracking Free Shipping Over $250 Secure Ordering 14-Day Returns Analytical Verification Each Certificate of Analysis (COA) is the independent laboratory report for one production lot it records the batch number, the measured purity, and the date of analysis, published against the exact product it belongs to